tiprankstipranks
Trending News
More News >
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
Hong Kong Market

Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Ratios

Compare
0 Followers

Shanghai Haohai Biological Technology Co., Ltd. Class H Ratios

HK:6826's free cash flow for Q4 2024 was ¥0.01. For the 2024 fiscal year, HK:6826's free cash flow was decreased by ¥ and operating cash flow was ¥0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.00 5.24 6.91 7.62 8.78
Quick Ratio
0.00 4.50 5.96 6.89 8.20
Cash Ratio
0.00 3.83 4.97 5.95 7.13
Solvency Ratio
-0.09 0.56 0.39 0.58 0.64
Operating Cash Flow Ratio
0.00 0.89 0.45 0.70 0.60
Short-Term Operating Cash Flow Coverage
0.00 3.23 17.77 7.00 3.32
Net Current Asset Value
¥ 8.73B¥ 2.66B¥ 2.54B¥ 2.82B¥ 3.25B
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.06 0.02 0.02 0.02
Debt-to-Equity Ratio
0.00 0.07 0.02 0.02 0.02
Debt-to-Capital Ratio
0.00 0.07 0.02 0.02 0.02
Long-Term Debt-to-Capital Ratio
0.00 0.03 <0.01 <0.01 <0.01
Financial Leverage Ratio
0.00 1.26 1.25 1.22 1.15
Debt Service Coverage Ratio
72.78 3.03 19.50 9.56 4.35
Interest Coverage Ratio
65.97 60.09 34.02 77.46 53.12
Debt to Market Cap
0.00 0.04 0.01 0.01 0.02
Interest Debt Per Share
0.02 1.24 0.73 0.63 0.64
Net Debt to EBITDA
0.00 -3.27 -5.41 -5.08 -7.56
Profitability Margins
Gross Profit Margin
55.14%70.34%68.79%71.98%74.78%
EBIT Margin
19.81%19.57%11.57%22.15%19.78%
EBITDA Margin
23.76%27.08%21.28%31.45%29.81%
Operating Profit Margin
18.40%16.64%12.30%21.97%19.67%
Pretax Profit Margin
17.34%19.29%11.21%21.86%19.41%
Net Profit Margin
15.57%15.79%8.58%20.13%17.37%
Continuous Operations Profit Margin
15.57%15.65%9.05%19.84%17.09%
Net Income Per EBT
89.83%81.87%76.56%92.05%89.51%
EBT Per EBIT
94.25%115.94%91.13%99.54%98.64%
Return on Assets (ROA)
0.00%5.86%2.62%5.07%3.65%
Return on Equity (ROE)
7.26%7.36%3.27%6.16%4.19%
Return on Capital Employed (ROCE)
0.00%6.86%4.05%5.95%4.44%
Return on Invested Capital (ROIC)
0.00%5.38%3.26%5.34%3.85%
Return on Tangible Assets
0.00%6.98%3.17%6.11%4.31%
Earnings Yield
5.76%4.77%4.47%6.67%4.62%
Efficiency Ratios
Receivables Turnover
0.00 6.65M 5.51 4.66 3.89
Payables Turnover
0.00 14.18 12.04 10.60 11.92
Inventory Turnover
0.00 1.49 1.35 1.38 1.31
Fixed Asset Turnover
0.00 1.70 1.49 1.40 1.27
Asset Turnover
0.00 0.37 0.31 0.25 0.21
Working Capital Turnover Ratio
0.97 0.87 0.67 0.53 0.38
Cash Conversion Cycle
0.00 220.04 305.66 307.88 342.08
Days of Sales Outstanding
0.00 <0.01 66.20 78.25 93.91
Days of Inventory Outstanding
0.00 245.78 269.78 264.06 278.80
Days of Payables Outstanding
0.00 25.74 30.32 34.44 30.63
Operating Cycle
0.00 245.78 335.98 342.32 372.71
Cash Flow Ratios
Operating Cash Flow Per Share
1.32 1.90 1.33 1.94 1.48
Free Cash Flow Per Share
0.46 1.10 -0.49 0.40 0.37
CapEx Per Share
0.86 0.80 1.83 1.54 1.11
Free Cash Flow to Operating Cash Flow
0.35 0.58 -0.37 0.21 0.25
Dividend Paid and CapEx Coverage Ratio
1.26 1.86 0.53 0.95 0.82
Capital Expenditure Coverage Ratio
1.54 2.37 0.73 1.26 1.34
Operating Cash Flow Coverage Ratio
0.00 1.56 1.96 3.24 2.42
Operating Cash Flow to Sales Ratio
0.16 0.24 0.11 0.20 0.20
Free Cash Flow Yield
1.42%4.21%-2.13%1.33%1.33%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.33 20.95 22.35 14.98 21.63
Price-to-Sales (P/S) Ratio
3.93 3.31 1.92 3.02 3.76
Price-to-Book (P/B) Ratio
1.21 1.54 0.73 0.92 0.91
Price-to-Free Cash Flow (P/FCF) Ratio
70.35 23.75 -46.98 75.18 75.17
Price-to-Operating Cash Flow Ratio
16.91 13.74 17.44 15.42 18.99
Price-to-Earnings Growth (PEG) Ratio
-1.39 1.09 -0.47 0.28 -0.51
Price-to-Fair Value
1.21 1.54 0.73 0.92 0.91
Enterprise Value Multiple
16.53 8.95 3.60 4.51 5.05
Enterprise Value
10.61B 6.39B 1.61B 2.48B 1.99B
EV to EBITDA
16.55 8.95 3.60 4.51 5.05
EV to Sales
3.93 2.42 0.77 1.42 1.50
EV to Free Cash Flow
70.42 17.39 -18.75 35.36 30.10
EV to Operating Cash Flow
24.63 10.07 6.96 7.25 7.60
Tangible Book Value Per Share
18.47 14.59 27.13 27.65 26.95
Shareholders’ Equity Per Share
18.47 16.90 31.78 32.44 31.03
Tax and Other Ratios
Effective Tax Rate
0.20 0.19 0.19 0.09 0.12
Revenue Per Share
8.26 7.88 12.12 9.94 7.48
Net Income Per Share
1.29 1.24 1.04 2.00 1.30
Tax Burden
0.90 0.82 0.77 0.92 0.90
Interest Burden
0.88 0.99 0.97 0.99 0.98
Research & Development to Revenue
0.14 0.08 0.09 0.10 0.10
SG&A to Revenue
0.20 0.16 0.19 0.16 0.16
Stock-Based Compensation to Revenue
>-0.01 <0.01 0.01 0.00 0.00
Income Quality
1.52 1.25 0.98 0.89 1.02
Currency in CNY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis